Frankfurt, Germany

Erich Bickel

This inventor holds 2 USPTO granted patents. Top assignee: Deutsche Gold- Und Silber-Scheideanstalt Vormals Roessler. Active years: 1979-1981.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Erich Bickel. Retrieved from https://idiyas.com/inventor/erich-bickel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.4

ph-index = 1


Company Filing History:


Years Active: 1979-1981

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Erich Bickel: A Pioneer in Theophylline Derivatives

Introduction

Erich Bickel is a notable inventor based in Frankfurt am Main, Germany, recognized for his contributions to the field of pharmaceuticals. With a portfolio of two patents, Bickel's work has focused primarily on processes for the production of basic substituted alkyltheophylline derivatives.

Latest Patents

Bickel's latest patents detail sophisticated processes for producing theophylline derivatives. The first patent outlines a method for synthesizing compounds where specific configurations and reactions are employed, including the use of bromoketones and aminoalkyltheophyllines. The second patent focuses on producing basic substituted alkyl theophylline derivatives through catalytic hydrogenation, incorporating protective groups and utilizing various solvents. Both patents reflect Bickel's in-depth knowledge and innovation in chemistry.

Career Highlights

Erich Bickel is affiliated with Deutsche Gold- und Silber-Scheideanstalt vormals Roessler, a prominent company in the field. His role here has enabled him to apply his inventive skills in practical applications within the pharmaceutical sector.

Collaborations

Throughout his career, Bickel has worked alongside notable colleagues, including Karl-Heinz Klingler and Karl H. Klingler. Collaborations with such professionals indicate a strong network of expertise and innovation within his field.

Conclusion

Erich Bickel exemplifies the spirit of innovation in the pharmaceutical industry. His patents not only contribute to the scientific community’s understanding of theophylline derivatives but also highlight the importance of collaboration in driving progress. As the industry evolves, Bickel's work remains a testament to the integration of chemistry and invention.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…